Latest profit margin for Applied Dna Sciences: -3557.55% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for APDN is -3557.55% as of June 2026. That compares with -1125.25% in the prior-year period — down 216.2% year over year. That is below the Materials sector average of 16.48%. Investors often review this figure alongside Applied Dna Sciences's historical trend and sector peers before judging valuation or financial health.
Over the past year, APDN's profit margin moved from -1125.25% to -3557.55% — a 216.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Applied Dna Sciences's valuation or profitability profile.
Against Materials companies, APDN currently prints -3557.55% for profit margin, while the sector average sits near 16.48%. That is roughly 21684.9% below the sector mean. Large gaps often invite a closer look at Applied Dna Sciences's growth, margins, and balance sheet.
Profit Margin shows how effectively Applied Dna Sciences converts resources into returns. At -3557.55%, APDN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1125.25% in the prior-year period — down 216.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting APDN's profit margin (-3557.55%), review year-over-year change from -1125.25%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.